the First Affiliated Hospital, Harbin Medical University
Harbin, Heilongjiang, 150001, China
Location status: Recruiting
NCT Number: NCT07087093
Studies have shown that aging can promote a variety of pathological processes, such as myocardial remodeling and cardiac dysfunction caused by ischemia-reperfusion injury and pressure load. Previous studies found that the level of circulating beta-hydroxybutyric acid decreased significantly with age. It has been reported that the ketogenic diet reduces the occurrence of tumors and neurodegenerative diseases in mice, improves motor coordination and endurance, and ultimately extends life span. Current research results have confirmed that ketone bodies have multiple mechanisms to exert beneficial effects on cardiovascular diseases. However, the effect of age-related cardiovascular disease has not been reported.
In order to further clarify the role of beta-hydroxybutyric acid in age-related cardiovascular diseases, find new intervention targets for elderly cardiovascular diseases, and develop new effective prevention and treatment measures for elderly cardiovascular diseases. We will further investigate this hypothesis by establishing a clinical cohort of the elderly population.
Interested in participating?
Request Info65 year–80 year
All sexes
Interventional
Not applicable
Harbin, Heilongjiang, 150001, China
Location status: Recruiting
It is predicted that by 2050, the total number of people over 65 years old in China will reach 400 million (accounting for 26.9% of the total population), and the number of people over 80 years old will reach 150 million. Population aging is the main driving force of cardiovascular diseases, and cardiovascular diseases in the elderly will become a major clinical problem threatening the health of our people and a social problem involving people's livelihood. Therefore, it is an important research direction in the cardiovascular field to deeply explore the pathogenesis of elderly cardiovascular diseases and find effective prevention and control targets.
Studies have shown that aging can promote a variety of pathological processes, such as myocardial remodeling and cardiac dysfunction caused by ischemia-reperfusion injury and pressure load. Previous studies found that the level of circulating beta-hydroxybutyric acid decreased significantly with age. It has been reported that the ketogenic diet reduces the occurrence of tumors and neurodegenerative diseases in mice, improves motor coordination and endurance, and ultimately extends life span. Current research results have confirmed that ketone bodies have multiple mechanisms to exert beneficial effects on cardiovascular diseases. However, the effect of age-related cardiovascular disease has not been reported.
In order to further clarify the role of beta-hydroxybutyric acid in age-related cardiovascular diseases, find new intervention targets for elderly cardiovascular diseases, and develop new effective prevention and treatment measures for elderly cardiovascular diseases. We will further investigate this hypothesis by establishing a clinical cohort of the elderly population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
KetoneAid Ke4 Pro Ketone Ester:20ml, tid po
Time frame: From enrollment to the end of treatment at 2 weeks
Expression of protein 53、protein 21 and protein 16 in human plasma used by western blot.
Time frame: From enrollment to the end of treatment at 2 weeks
Expression of monocyte chemoattractant protein-1 and interleukin-6 in human plasma used by enzyme linked immunosorbent assay.
Time frame: From enrollment to the end of treatment at 2 weeks
The ankle-brachial index value was measured by dopplex ankle-brachial index detector.
Time frame: From enrollment to the end of treatment at 2 weeks
Use cardiac echocardiography to assess the ejection fraction level
Time frame: From enrollment to the end of treatment at 2 weeks
NT-proBNP level was used by chemiluminescence immunoassay.
Contact information is provided by the study sponsor or research team.
First Affiliated Hospital of Harbin Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06951633
Respiration Disorders, Respiratory Disorders
Wieliczka, Poland
View Trial DetailsNCT02155686
the Elderly
Limoges, France
View Trial DetailsNCT06669338
Anxiety, Anxiety Disorders
Muğla, Mentese, Turkey (Türkiye)
View Trial DetailsNCT04242745
the Elderly
Izmir, Turkey (Türkiye)
View Trial Details